We are live on ! Find out more
Cathie Wood

Cathie Wood ARK Investment Management

AUM $15.4B
1-Year Est. Return 50.29%
 

Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.

This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+50.29%
3 Year Est. Return
+250.43%
5 Year Est. Return
+91.72%
10 Year Est. Return
AUM
$347M
AUM Growth
+$72M
Cap. Flow
+$23.1M
Cap. Flow %
6.66%
Top 10 Hldgs %
43.67%
Holding
109
New
7
Increased
73
Reduced
23
Closed
5

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$5.87M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.43M
3
NFLX icon
Netflix
NFLX
+$4.48M
4
DDD icon
3D Systems Corp
DDD
+$3.58M
5
NVDA icon
NVIDIA
NVDA
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 28.55%
2 Healthcare 26.21%
3 Communication Services 14.97%
4 Industrials 13.37%
5 Consumer Discretionary 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNT icon
101
Avient
AVNT
$4.1B
$31K 0.01%
895
+200
+29% +$6.71K
PX
102
DELISTED
Praxair Inc
PX
$28K 0.01%
234
+54
+30% +$6.35K
CRS icon
103
Carpenter Technology
CRS
$24.4B
$27K 0.01%
715
+163
+30% +$6.36K
KODK icon
104
Kodak
KODK
$963M
$22K 0.01%
1,909
+419
+28% +$5.73K
AMBA icon
105
Ambarella
AMBA
$3.23B
-2,846
Closed -$154K
BMRN icon
106
BioMarin Pharmaceuticals
BMRN
$12.9B
-960
Closed -$80K
UA icon
107
Under Armour Class C
UA
$2.25B
-7,562
Closed -$190K
VJET
108
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
-30,925
Closed -$444K
MENT
109
DELISTED
Mentor Graphics Corp
MENT
-13,878
Closed -$512K

Similar funds

Cathie Wood's Q1 2017 Portfolio in Review

As of Q1 2017, Cathie Wood held 109 positions worth $347M, up 26% from $275M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cathie Wood deployed $23.1M of net new capital in Q1 2017, opening 7 new positions and adding to 73 existing holdings. Its largest new stake was Editas Medicine: 229,922 shares worth $5.13M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Illumina, an estimated $5.87M trimmed.

  • Cathie Wood's largest Q1 2017 buy was Editas Medicine: 229,922 shares worth $5.13M.
  • Cathie Wood added most to Ionis Pharmaceuticals in Q1 2017, an estimated $5.43M increase.
  • Cathie Wood's biggest Q1 2017 reduction was Illumina, cutting an estimated $5.87M.
  • Cathie Wood fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $512K.
  • Cathie Wood's ten largest holdings make up 44% of its $347M portfolio in Q1 2017.
  • Cathie Wood opened 7 new positions and closed 5 in Q1 2017.
  • Cathie Wood's portfolio value rose 26% quarter-over-quarter to $347M.

Based on ARK Investment Management's 13F filing for Q1 2017, filed 15 May 2017.